throbber
lnternah<mal Journal of Pharm;,ceutics 2~ (2000) 63-\70
`
`XP001183717
`international
`journal of
`pharmaceutics
`
`www.dscvicr.oom(locatc/iJpharrn
`
`Influence of Vi tam in E TPGS on the properties of
`hydrophilic films produced by hot-melt extrusion
`
`MichaeJ A. Repka*, James W. McGinity
`College of PhamuU"}'. University of Tl·xas at Austin. Austin. TY 787/.?, USA
`
`Re<:eived 21 December 1999; n:ceived in reVIsed forrn 27 Mardi 2000. accepted 27 March 20()()
`
`-- - - - - - -
`
`- - - ----
`Abstra('t
`
`Films containing hydroxypropykellulose (HPC) and polyethylene oxide (P~9J were prepared using a Randcastle
`extruder (Model 750) with and wirhom Vitamin E TPGS (TPGS, o-a-tocopheryl polyethylene glycol !OCX> succinatd
`as an additive. Conventional plasticizer~ induding polyethylene glycol 400 (PEG 400), triethyl citrate (TEC), and
`acctyitributyl citrate (ATBC) were also incorporated into films containing a .50:50 blend of HPC and PEO. The
`physical- mechanical properties including tensilt: strength (TS) and percent elongation (%E) were determined on an
`lnstron according ro the ASTM standards. Glass transition temperatures ( T~) of the extruded films were determined
`utilizing a DSC 2920 M,Jdulated differential scanning calorimeter and THERMAL ANALYST 2000 software. Gt:l
`permeation chromatography was u:;cd to study the stability of the polymer fibns under the processing conditions. The
`addition of J, 3, and 5% Vitamin E TPGS, respectively, decreased the glass transition temperature of the extruded
`ftlrns t;Ontaining either a 50:50 or 80:20 ratio of HPC to PEO in an almost linear fashion. In addition, the presence
`of 3°!1> Vitamin E TPGS lowered the T, over II °C when compared with the HPCiPEO 50:50 blend film without
`TPGS, thus functioning as a plasticizer. The tensile ~trength dccrcnscd with increasing concentrations of TPGS, and
`the 0/oE incr<!ased over 3-fold when compared with the HPC/PEO film that contained no additives. The film
`containing 3% Vitamin E TPGS had a similar tt~nsile stn~ngth to that of the films c:ont.ai.oing 3% PEG 400, and a
`3-fold increase in perccut elongation whcu compared with tl1t filtll.s containi11g 3% TEC and J% ATBC. Iu addition,
`the Vitamin E TPGS facilitated the processing of the HPC/PEO films by decreasing the barre! pressure, drive amps,
`and torque of the extruder equipment.~) 2000 Ebevier Science B.V. All rights reserved.
`
`1\e\words: Vitamin E TPGS~ Hot melt; Ext•-uded films: HydroxypropylcellulosG~ Physical mechanical properties; Glass transition
`temperature; Polyelhylcne oxide
`----------------·----------------------------------
`
`• Corr,,spondiug author. Tel.: + t-512-471-tl8-11: fax: + 1-
`512-471-2746.
`£-mail add•·ess: m.repka@.matl.uteKa1i..cdu (M.A. Repka\.
`
`I. introduction
`
`Vitamin F TPGS NF (TPGS, D-::x-tocopheryl
`polyethylene glycol \000 succinate) has been uti(cid:173)
`lized for numerous applications in phannacemical
`dosage forms. Its chemical structure coma ins both
`
`0~78-517J/OO/$ - s<:.e ti·om ma11er «.:' 2000 Elsevier Sc,.,nce B.V. All rights reserved.
`Pll: SO'l78-5J7J(00)00418-X
`
`SNS[lOCID· <Xi> ............ ' 1fl3717A_I .. >
`
`MSL_0003140
`
`RBP_TEVA05017998
`
`TEVA EXHIBIT 1042
`TEVA PHARMACEUTICALS USA, INC. V. MONOSOL RX, LLC
`
`

`
`64
`
`M.A. Repka, J. W. /IJcGinity
`
`International loumal of Phannaccuti,:s 202 120001 63·· 70 X PQQ 1183 71 7
`
`a lipopbilic and a hydropbilic moiety, making it
`similar to a convemional surface-active agent (Fig.
`!). The chemical properties l)r lhis distinctive com(cid:173)
`pound have suggested its use as a solubilizer, all
`emulsifier, ao absorption enhancer, and as a wa(cid:173)
`ter-soluble source of vitamin E (Eastman Chemi(cid:173)
`cal Company, 1998). TPGS has a melting point of
`approxi.miuely 38°C and irs degradation tempera(cid:173)
`ture bas been reported tO be 199.3°C. 'T'hesc phys(cid:173)
`ical properties coupled with its chemical properties
`make TPGS a potential candidate for hot-melt
`ext.rusiou applications.
`Several studies have demonstrated the ctTecrs of
`TPGS as an absorption enhancer (Traber et al .. ,
`1986, 1987; Sokol et al., !99Ja,b; Argao et a!.,
`l 992; Sokol er al., 1993; Chang et a!., 1996;
`Btidgers et al., 1998). Sokol et ul. (1993) con(cid:173)
`ducted a multi-center trial of TPGS for treatment
`of vitamin E deficiency in children witb chronic
`cboles.tasis . 'll1ese researchers reported that TPOS
`appeared to be a safe and effective form of vitamin
`E for reversing or preventing vitamin E deficiency
`during chronic childhood cbolestasis. Traber et al.
`( 1986) proposed a mechanism for enhanced <X- to(cid:173)
`copherol absorption by TPGS. Since TPGS can
`fonn micelles, it can cross from the intestinal
`lumen 1nto the mresri11al cel!s. "This mechanism has
`suggested the use 0f TPGS as a controlled drug
`deliveJy vehicle. Other studies have demonstrated
`an enhanced absm·ption of vitamin D in chronic
`cholesta tic liver disease or infancy and childhood
`(Argao et al., 1992) and unproved absorption of a
`model HI.V protease inhibitor (Bridgers et al.,
`1998 ). lsmailos et a l. (1994) concluded that 'l1>GS
`increased the solubility of cyclosporine, resulting
`i.n an increased bioavailability and thus an in(cid:173)
`creased absorption.
`
`I Chc.mJc"l ~tructurc of rhe pnncipal component of
`Fig
`Vitamin E TPGS.
`
`the
`Several studies have a \so demonstn1ted
`value of TPGS as a water-soluble vitamin E sup(cid:173)
`plement ( Hidiroglou et a!., 1993; Traber et a!.,
`1994; Di.mitrov et al., 1996; Socha et al., 199"/).
`Socha et al. ( 1997) concluded that oral TPGS
`supplementation of cholestatic children can
`quickly llOrmalize serum vitamin E levels. Dim(cid:173)
`itrov et a!. (1996) reported rhat in cases of
`cholestasis and other forms or lipid malabsorp·
`tion, oral adminislration of TPGS is the treatmem
`of ciloice.
`Few, if any, studies have been reported in tbe
`literature concerning
`the physical mechanical
`properties of Vitamin E TPGS in hydrophilic fi.l.Ir.s
`produced by a hot-melt extrusion technique. Due
`10 rhe tmique properties of TPGS as a solubili.zer,
`absorption enhancer and a potential controlled
`drug release vehicle, transdcmtal and transnn.1·
`cosa! applications are also possible. The \'>t~jecJ.ive
`of this study is
`to investigate the influence of
`Vitamin E TPGS on tbe properties of hydrophilic
`films produced by a hot-melt extrusion technique.
`In addition, the effect of TPGS as a processing aid
`for hot-melt extrusion is reported.
`
`2. Materials and methods
`
`2.1. Materials
`
`VItamin E TPGS NF was provided by Eastman
`Chemical Company (Kingsport, TN). Hydrox·
`ypropylcellulose (HPC) (KluceJ® HF; molecular
`we1gbt (MW), I 150 000) was obtained from the
`Aqualon
`DEL
`Company
`(Wilmiogtoo,
`Polyerhylene oxide resin (PEO) (PolyOx*' WSR;
`MW, 1 000 000) and polyethylene glycol 400 NF
`(PEG 400) (Carbowax® 400) were obtained from
`Un1on Carbide Corp. (Danbury, CT). Triethyl
`citrate (TECJ and acctyltributyl citrate <ATBCJ
`were. provided by Morfiex, Inc. (Greensboro, NC).
`
`2.2. Processing methods
`
`2.2. I. Matenal preparatwn and blending
`HPC aud PEO were dried at 50°C for 24 h
`prior to mixing. Vitamin E TPGS was freeze(cid:173)
`dried, lyophilized, and sieved (60 mesh) prior to
`
`MSL_0003141
`
`RBP_TEVA05017999
`
`TEVA EXHIBIT 1042
`TEVA PHARMACEUTICALS USA, INC. V. MONOSOL RX, LLC
`
`

`
`M.A. Repka, 1. Hi. AJcGml/_1'
`
`International Journal vf Pha11nace<llics 202 (2000) 63 · 70
`
`XPOOI 183717
`65
`
`blending with rhe two ratios of HPC and PEO
`(50:50 and 80:20). The plasticizers were incorpo(cid:173)
`rated slowly into a Liquid-Solids Blender.,.. (Pa(cid:173)
`terson-Kelley Co.l containing
`the HPC/PEO
`blends. All additives were blended for ~0 min. 'J11e
`batcb size was 1.0 kg..
`
`.2.2.2. Hot-melt extrusion
`A Randcastle Microuuder', (Model RCP-0750)
`was pre-heated to J 70°C melr temperature. For
`purging purposes, polyethylene pellets wt•re added
`to the hopper and passed through the extruder for
`5 mill Hbis procedw·e was repeated for each indi(cid:173)
`vidual batcb). The blends of HPC;PEO and Vita(cid:173)
`min E TPGS or Qlasricizer was placed in the
`hopper and exrrudcdt0013'r.ain a homogeneous
`film with a thickness range from 10 to 13 nul (I
`mi.!= 25.4 J.lm or 0.001 inch) or 0.254·-0330 mm.
`The extrusion temperatures for each film were
`depe11dent on the fotTnulation extruded. The films
`were extruded at their respective optimal rem per a·
`tures, ranging from 180 to 190°C. Processing time
`was less tban 2 min for all tllms produced. Tile
`film was collected in mils, labeled, and scaled in 5
`mil polyethylene bags (25°C, 50% relative humid(cid:173)
`ity). The width of the fil.rns produced was approx(cid:173)
`imately 5.00 inches ( ± 0.25). Random samples
`were taken from the extruded films for testing.
`Initial testing was conunenced after 7 days of
`storage.
`
`2.3. Mechanical 1esting appararu:>
`
`The physical-mechanical properties of the films
`were distinguished utilizing an lllstron 4201 tcst(cid:173)
`mg apparatus with a head speed of 10 mmfmin.
`The standard test method for tensile properties of
`thin plastic sheeting by the American Socie[y for
`Testing Materials, method D 882-95a, was used to
`investigate the mechanical properties. Six samples
`from each formulation were tested. The initial
`grip separation was 100 mm. Testing conditions
`for all films were 25°C and 50% relative humidity.
`
`2.4. Calculations
`
`force or load (F)
`Tensile strength (a)=
`MA
`
`where F is the maxi.mwn load and MA is the
`minimwn cross-sectional area of the film speci(cid:173)
`men. Results were converted to megaPascal units
`(MPa) .
`
`where L., refers to the initial length of rhc film
`sample and L is the elongation at the moment or
`rupture.
`
`Elongation percent= ex 100
`
`2.5. Physical characteri=arion
`
`Di.!Terential scanning calorimetry (DSC 2920
`Modulated DSC, and f'HERMAL ANALYST 2000
`software: TA Instrwnems, New Castle, DE) was
`milized to determine glass transition temperatures
`( T,). lJitrahigh pure nitrogen was used as the
`purge gas at a flow rate of 1 SO mljmm. Approxl(cid:173)
`mately 5 -·10 mg of sample was weighed and
`scaled in a nonhctmetic aluminum pan. All stud(cid:173)
`ies had a temperature ramp speed set at 10°C/
`min.
`Gel permeation chromatography (GPC) was
`used to provide a qualitative study of the polymer
`blend stability. A Waters system,
`including a
`WlSP model 710B auto sampler and a model 510
`salven t deli very system, was utilized. Ultrahy(cid:173)
`drogel"" 1000 and 2000 columns connected
`iu series and a model 410 diLTerential refractome(cid:173)
`ter were
`detector. Distilled
`used
`as
`the
`water containing 0.1 M sodi~Lm nitrate was uti(cid:173)
`lized as the mobile phase at a flow rate of l
`mljmiu.
`
`2.6. Statistical analy.vi.l'
`
`Calculations were performed in the following
`rnauuer.
`
`Statistical analysis was determined utili.ziug
`one-way analysis. of variance. A statistically sig(cid:173)
`nificant d1fference was considered when P < 0.05.
`
`MSL_0003142
`
`RBP_TEVA05018000
`
`TEVA EXHIBIT 1042
`TEVA PHARMACEUTICALS USA, INC. V. MONOSOL RX, LLC
`
`

`
`66
`
`M.A. Repka, J.I·'V. McGinily
`
`lntemariona/ Journal of _Pha•·maceulia 20.? (:?.0001 63-70
`
`XP001183717
`
`46 , - - - · · • "»> ' " " " " " " " " "
`
`4(\ ~ ·-
`
`-
`
`35 , ......... ..
`
`~: r.···· __ ··_"· __ _
`
`:.-~-~-~i~~ii~·iiiR
`~.!!.~~.1PE0{~2())_
`[
`__ J
`
`:zo .;. ............... .
`15 ., .................. _ _._ .. ..
`
`................ _ . _ ___ ._..l
`
`0%
`
`3%
`1%
`Percent Vitamin f TPGS
`
`5%
`
`Fig. 2. Glass transition temperatures of films containing ditTer(cid:173)
`c:rtt levels of V•tamin E TPGS incorporated iuto two forulula(cid:173)
`tions of HPC/PEO bot-melt extruded films (n = 4).
`
`\..
`
`BPCIPEO :50 50
`TPOS5% - - -
`........................................
`
`-41.1
`
`-41.%
`~
`
`~ -4M -t • .. .6
`
`Iii:
`01
`:!
`
`-41.8
`
`-UI
`
`-l-1
`
`II
`
`zs
`
`i
`!
`!
`\ i
`-+~' ............ ,_ ___ +-----!
`. 100
`50
`7:1
`TemperatlD"e ('C)
`
`Fig. \. OiiTcrcntial scanning calorimetry thermograrns of hot(cid:173)
`mel! ""~rruded films consisting of HPC/PEO in a ~O:SO raliL~
`(dashed line) and the HPC/PEO 50:50 ratio with 5% Vitamjo
`E TPGS as an addihve (solid line).
`
`40r-·~~~~~----------~~
`35
`lO +------
`•• 25
`E 20
`"' ,_ 1 s
`10
`5
`0
`
`PeG 4IMI Vlt E ll'GS TEC 3'11.
`l'lo
`)'Y,
`l"ig. 4. Glass transition temperatures of HPC/PEO (50:50)
`bot-melt <'xtruded films containing Vitamin E TPGS and thrC'~
`conventional plasticizers (n"' 4).
`
`ATBC 3'11.
`
`0'4
`
`3. Results and discussion
`
`As seen from Fig. 2, the glass transition temper(cid:173)
`atures of the two formlllarion ratios of HPC and
`PEO decreased in an almost linear fashiou wtth
`the addition of 1, ~ and 5% Vitamin E TPCIS.
`Although the T.., of the HPC/PEO (80:20) film
`with no TPGS present was slightly higher than
`rhar of rhe 50:50 ratio, wtth rhe addition of only
`1% TPGS. tbe Ts of Lhe two films were almost
`equivalent. ln addition, the inc0rporation of 5%
`TPGS into the HPCjPEO films (50:50 and 80:20)
`lowered the glass transition temperatures by ap(cid:173)
`proxima !Ciy
`l 7 and l8"C, respective! y (36.0 to
`19 soc, and 39.7 to 2l.:i 0 C), compared with the
`HPC/PEO fllms with uo additives CP < 0.05) (Fig.
`3). By lowering the glass transition temperature,
`TPGS acts as a plasticizer for the two polymer(cid:173)
`blended films. 1l1ese effects are a result of the
`TPGS weakeni11g the mterrnolecular attractions
`within the polymer blends and iucreasing the
`free voluJJ1(\ allowing the polymer
`pol.ymers'
`chaiu-; to move more easily and 10 become more
`flexible (Gutierre7-Rocca and McGinity, 1993;
`Wheatley, and Sreuernagel, 1997).
`The Tg of the HPC/PEO (50:50 ratio) film
`containing ~% TPGS and t"hree other conven(cid:173)
`tional plasticizers at the same concentration was
`determmed (Fig. 4). The film containing TPGS
`(3%) lowered the glass transition temperature over
`II oc from the HPCjPEO, 50:50 blend film (36.0
`to 24.9°C). In addition, the 3ryo TPGS-incorpo(cid:173)
`rated film reduced the T& to rhc same degree as
`the ~%PEG 400, and was significantly better than
`films containing 3% TEC and 3% ATBC <P <
`0.05). The efficiency of a plasticizer is related to
`its chemical structure and the interaction between
`its l'unctiot1al groups with those of the polymer or
`polymers (Gutierrez-Rocca a11d McGinity, 1994).
`The ampiphilic nilturc of the TPGS molecule,
`with the polyethylene glywl moiety serving as the
`polar head, enables it to function as a plasticizer
`for
`the
`two hydrophilic polymers
`(Eastman
`Cherrucal Company. J 998).
`Fig. Sa,b show the tcnsi.lc strength and percent
`elonga Lion, respectively, or the two HPCjPEO
`polymer blends as a function of incrensmg per(cid:173)
`centages of VitamiJ1 E TPGS. The tensile strengrh
`(TS) ts indire-etly proportional to the percentage
`
`BNSt::<X.:t D <XP ...
`
`118371"1A
`
`~
`
`.,.
`
`MSL_0003143
`
`RBP_TEVA05018001
`
`TEVA EXHIBIT 1042
`TEVA PHARMACEUTICALS USA, INC. V. MONOSOL RX, LLC
`
`

`
`M.A. Repka, J. W. MrGinity
`
`lril<:l'natwnal Journal of Pharmaceutics 101 i2000i 63-70
`
`XP001183717
`67
`
`of TPGS, while the percent elongation (%E) is
`directly proportional. No differences in these two
`physical-mechanical properties were round for
`the two HPCjPEO blends. 1bis finding is not
`surprising since there were no significant differ(cid:173)
`ences in the glass transition temperatures between
`the two polymer blends at each level of TPGS
`ine0rporated. The percent eloogati011 increased
`over J-fold for the 5% TPGS-cootaining film
`when compared with films containing no TPGS
`tP < 0.05). These findings are also consistent with
`tbe T 2 data that were presented earlier. Plasticiza(cid:173)
`tion of a polymer will decrease the polymeric
`intermolecular interactions to provide a greater
`freedom of movement
`polymeric
`for
`the
`molecules. Therefore, the film is more deformable
`(Wang et al., 1996). The tensile strength is de(cid:173)
`creased, and
`flexibility and elongation
`is
`ill(cid:173)
`creased, as is reponed in this study.
`The physical-mechanical studies demonstrate
`the comparable effectiveness of Vitamin E TPGS
`as a plasticizer (Fig. 6a,b). Tbc 3% TPGS-incor-
`
`50
`i 40
`!.
`i 30
`c: t 20
`"' .!!
`! 10
`{!
`
`0
`(a)
`
`25
`
`c: 20
`
`.Sl J 15
`"' i 10
`
`!. 5
`
`0
`
`(b)
`
`D%
`
`3"111
`1%
`Percent Vitamin E TPGS
`
`Porc:ent Vitamin E TPGB
`
`Fig. 5. (a) l'ensile strength and (b) p~rccnt elongation of
`difl .... oeut level; or Vitawiu E TPGS lfOCOrjJOfat<:d into twu
`formulatoons of HPC/PEO hot-melt extruded films (n = (l).
`
`(a)
`
`PEG 400 VItamin E TEC :J% A TBC 3%
`3%
`TPGS3%
`
`0%
`
`(b)
`
`PEG 400 Vitamin E TEC 3% ATBC 3'4
`TPGS 3%
`3%
`
`0%
`
`Fog. 6. (a) Tensile strcn&tb and lbl percent elongation or
`HPC/PEO 50:50 ratio hot-mdt extrude-d films cootammg Vita(cid:173)
`min E TPGS nnd thru conventional plastici7.ers (n- 6).
`
`pora ted film had a similar tensile strength to that
`of the 3% PEG 400-containmg film (17.9 com(cid:173)
`pared with 14.8 MPa). However, tbe TS of the
`TPGS-contatning film was significantly lower than
`the films incorporated with 3% TEC, ~% ATHC
`aod tbe HPCjPEO film (50:50 blend) containing
`no additives. TI1e ~% TPGS film also exhibited an
`almost 3-fold
`increase
`in percent elongation
`(14.9%) when compared with that of the TEC,
`ATBC. and 0% TPGS-containing films (6.4, 5.8
`and 4. 7%. respectively). Thus,
`the hydrophil.ic
`moiety of the Vitamin E TPGS molecule was
`more effective in dismpting the intennok..cular
`interactions of the HPC/PEO 50:50 film, allowi.ng
`a greater degree ot' polymer chain freedom than
`either TEC l'r ATBC. Only the ~% PEG 400-in(cid:173)
`corporated film had a )!.reater perC'..etlt elongation
`(21.3%) than the T1lGS tilm. Tb1s may be ex(cid:173)
`plained by the lower molecular weight of PEG
`compiired with the TPGS. I femamaki et al. ( 1994)
`presented
`similar
`finrlings. These
`researchers
`
`BNSOOCID. <%>'
`
`. 1 l83717'A_I_>
`
`MSL_0003144
`
`RBP_TEVA05018002
`
`TEVA EXHIBIT 1042
`TEVA PHARMACEUTICALS USA, INC. V. MONOSOL RX, LLC
`
`

`
`68
`
`Af.A. Repka. J.IV. ft1cGmity
`
`lntcrnallonal fo11mal of Phannacr:uncs 202 (2000! 6.1 70
`
`XP001183717
`
`found that percent elongation or ductility was
`primarily attributed lO the molecular weight or
`the polymeric plasticizer. As the tnolecular weight
`or size of the PEG (or PEG moiety) is increased.
`rhe mole fraction of available hydroxyl groups ro
`interact. with the reactive sites of molecules will
`decrease (Rowe, 1976). In this case, the PEG
`moiety is of higher molecular weight than the
`PEG 400 molecule, therefore decreasing t.he abil(cid:173)
`ity of TPGS to interact with the reactive hydroxyl
`groups of the HPC and PEO. Thus, the TPGS
`film would be less elastic. In addition, PEG is
`composed of tbe same structural unit as PEO, but
`has a much lower molecular weight than PEO.
`Since PEG and PEO have the same repeating
`unit, they were completely miscible in the solid
`state (Zbang and McGinity, 1999). Tbe PEG
`molecules between PEO chaius were able to more
`effectively weaken t.l1e cohesive inr.eractions be(cid:173)
`tween the PEO chains, thereby increasing the
`inter-cbai.n space between
`the PEO molecules.
`However, as was reported by Repka et al.. 1999,
`the PEG 400-comaining fiLms may have stability
`concerns upon aging.
`"Ihe i11tluence of V1tarnin E TPGS on process(cid:173)
`ing conditions of hot-melt extruded films is re(cid:173)
`poned in Table 1. In a bot-melt extrusion process,
`polymers are subjected ro both thermal and shear(cid:173)
`ing stresses. The temperarure can contribute w
`depolymerization of polymer chains, whereas
`chain scission may result from the shearing effects
`of the screw (Zhang and McGi.oity, 1999). In the
`absence of TPGS, films could not be processed at
`tso•c due to the high viscosity of the polymer
`blend and a torque that exceeded the capacity of
`tbe extruder (50 N m). The processing tempera(cid:173)
`ture had to be increased r.o a minimum of 190°C
`
`to obtain a HPCjPEO 50:50 rati\1 film. Increasing
`the temperature is the most common practice to
`facilitate a polymer extrusion process i.n the plas(cid:173)
`tic ind~tstry. Melt viscosity decreases exponen(cid:173)
`tially wirb respect to an increase i.n temperature
`(Nielsen, 1977). At 180°C, a film with as little as
`1 ryo TPGS could be produced. However, as the
`percent TPGS increased, the barrel pressure, drive
`amps, and torque all decreased significantly <P <
`0.05). Th\IS, in addition to TPGS plasticizing the
`HPCJPEO films, it was also an excellent process(cid:173)
`ing aid in tbe extiUsion process. Indeed, due to
`the decrease in melt viscosity with increasing
`TPGS concentration, the films incorporated witb
`TPGS could be produced at a lower temperature
`and/or a higher screw speed. "ll1is would decrease
`the potential for degradation of both the poly(cid:173)
`mers and drugs rhar may be incorporated in the
`fil.m.
`Fig. 7 shows the results from the (3PC studies.
`As one can observe, there is a shift to the left of
`the curve represenung tbe film containi.1.1g 3%
`TPGS compared with that of rhe curve of the
`HPCfPEO 50:50 ratio film with no additives.
`These findings demonsrrared that TPGS decreased
`the degradation and chain scission of the polymer
`blend and help stabilize the PEO that is suscepti(cid:173)
`bLe to rhermal oxidation. In addition, when Vita(cid:173)
`min E 0.5"/r, was added to the powder blend, there
`was no further shift than occurred with the 3%
`TPGS-incor·porated .film.
`Vitamin E TPGS is a viable candidate for in(cid:173)
`corporation into hot-melt extruded films com(cid:173)
`posed of HPC and PEO. TPGS functioned as a
`plasticizer for these hydrophilic films since it low(cid:173)
`ered the glass transition temperature and
`in(cid:173)
`creased
`the percent elongation as the TPGS
`
`Tabl~ I
`Pro~:essing condJUons for h(>l-melt extruded films containmg a 50:50 ratio or hydro~ypropylcellulosc to polyethylene oxide with
`Vitamm E TPGS a~ an additi vc (n = 4)
`
`Vitamm E TPGS 1%)
`
`Melt temperature: (°C)
`Prc:ssu rc: (psi)
`Drive lA)
`Torque (N m)
`·--·-·-- ---·-·······-··-·······-···-·--··--··· .. ····-·····-· .. ·-----.. ·--·----·---
`0
`> 3000
`180
`;> 4.00
`25
`Overload
`190
`()
`3.84
`'!lllll
`40
`40
`:n
`I
`180
`1800
`HJ6
`40
`J
`180
`1500
`2.8
`40
`2.6)
`5
`2.07
`180
`40
`1100
`21
`----·-·····-············-·--··-·········-··-····----·--·····-······-···-············---·---·············-·········---·---···----······--·······-····················-········
`
`Screw spcc:d
`
`BNSOOCID: <XP ..
`
`......... ' 103717A. _ _I_>
`
`MSL_0003145
`
`RBP_TEVA05018003
`
`TEVA EXHIBIT 1042
`TEVA PHARMACEUTICALS USA, INC. V. MONOSOL RX, LLC
`
`

`
`M.A. RC!pka. ). I·V. McGinity
`
`lntcmalional h•urnal of Pharmac:culics 202 12000) 63 70
`
`XP001183717
`69
`
`' I
`
`I
`I
`
`' I
`
`I
`I
`I
`I
`I
`
`I . . I
`.
`I . I
`I . I
`
`D.IIO
`
`2.511
`
`..
`• 2.110
`1
`.. '.so
`' Q ..
`
`I
`
`'.110
`
`I
`I
`I
`
`. I
`' I • I
`I • '
`
`HJ>CfPEO 50:50 - (cid:173)
`
`TPGS 3% - - --
`
`I
`I
`I
`
`I
`
`'11.
`
`!Jver d.seas,e nf infancy and childhood. Pectiarr. Res.
`146 150.
`, Silver, 1.. and Collin, M
`Rridg~r~. A ... V1ckc:rs, A .. Yu. l
`1998. Vitamiu E-TI'GS c.nhaoccs
`the absorpt10l\ of a
`m<'Xiel f-JIV protease inhibitor by inhibiting an apk:ally
`polarized efftux system. PharroSci. Suppl. I ( J) S-76 .
`Chang. T.. Benet, L.Z., Hebert. M.F., 1996. The etlect of
`water-soluble vnamm Eon cyclosporine pharmaook.mctics
`m healthy volunteers. Clio. Pl1annacol. Ther. 59, 297-.~03.
`Dimitrov, N.Y .. Meyer-Lc:ecc. C., McMillan . .1.. Gilliland. 0 ..
`PerloiT, M .. Malone, W .. \996. Plasma alpha-tocopherol
`concentrations after >upplemt·ntarion with water and fat
`>Oiublc vitarolll. E. Am. J. Clin. Nutr. 64, ~29-J:~5.
`Eastman Cbemic.1l Company, 1\198. Vitamin E TI><Js NF.
`Propertic~ and
`applications, Publi..:ation EFC-2261\ .
`Kmgsport. TN, Octobc:r.
`Gutierrez-Rocca. J.C., McGinity. J.W., 199.~. lnfil.lencc of
`aging on the pbysical-mcchanical properties of acrylic resin
`fi ltns cast from aquc:oU> dispersions and organic solutions.
`Drug Dcv. Ind. Pbarm. 19, 315-1>2.
`Gutierrez-Rocca, J.C., McGinity .
`lnfillence o!'
`.I.W., 1994.
`wattr soluble and insulubh: pla~ti~,;i<Gcrs ou the phy>t<;<~l :.nd
`mechanical propert1es of acrylic rcsm copolymers. Int. .1.
`!'harm. 103, 293-301.
`Heillllrnaki, .I.T., Lehtola. V.M .. N1kupaavo, P .. Yhruust .
`.I.K, 1994. Me.cbanical >tnd moistllre permeability proper·
`tics of aqueous-based hydroxypropyl mcthylcc:llulosc coal·
`tog systems plasticized wilh polye.lhylene glycol. Int. J.
`Ph.arm. \\2. 191-·196.
`Htdrroglou. N .. Wolyoetz. M.S .. Mc:!)owefl. L.R., Papas.
`AM., i\utaplt, M. Wilkmson .. N.S ..
`\993. Serwn total
`cholesterol.
`high-dcn51ty
`lipoprotein-cbolcsterol
`and
`rriglycende concenrrarioo~ in bmbs following supplemen(cid:173)
`tation with various forms of tocopherol. Rcprod. Nutr.
`Dev. ~:1. 263--268.
`lsmai!os. G .. Rcppas. C .. Ma~hcras, P .. 199-l. Euuanccmcnt of
`c•y~:losponn A
`solub1hty
`by
`o-alpha-tocopheryl(cid:173)
`p<Jiycthylcnc-glycol-1000 su..:cinatc (TPGS). Eur. J. Pharm.
`Set. I. 269-271.
`N1clsec. I E .. 1977. Polymer Rcology. Marcel Dekker, New
`York. pp. :ll-44.
`Repka, M.A., Gerding, T.G .. Repka. S.L., McGinity, J.W.,
`1999. Lu.fil.loencc of plastici;:crs and drugs ou the physical(cid:173)
`rn<~ch.anic'al properties of hydro~<ypropylcellulose films pre(cid:173)
`pared by ltot melt extruston. Drug Dcv. fnd. Pbarm. 25.
`6~~-6~-n.
`Rowe. R.C., 1976. Microinctenration -···a merh,)d lor measur(cid:173)
`ing the clastic prOperties and hardness of film< 00 C4?nVCl1•
`J. Pharm.
`llonal\y coated
`tablets
`(communications).
`Pharmaool. 28. 310- 311.
`Sucha, P., Kolctzko, B., Pawlowska, J., Proszynska. K ..
`Sm:ha. J., 1997. Treatment ol' cholcstalil: children wah
`water-soluble vitamin E (alph.a-tocopheryl polyethylene
`glycol '"ecinate:l: eiTects ''" <erum vitamin F. lipid perox.
`ides, and polyunsaturated fatty acids . .1. Pediatr. Gastrocn·
`tcrol. Nutr. 24.189-193.
`
`D.SII
`
`____ ....
`O.DD
`t.DO
`
`.. _______ .. _
`
`2.110
`
`:1.011
`to1 ...... -..
`
`•
`
`4.00
`
`5.011
`
`Fig. 7. Gel permeation chromarograms of' hot-melt extruded
`tilms e<)nsisting of HPC/PEO in a 50:50 ratio and the HPC/
`PEO 50:50 ratio witb 5% Vitamin r: TPGS as an .additive
`(n =6).
`
`content increased. TPGS was also found to func·
`tion comparably with the conventional plasticizers
`tested. Vitamin E TPGS was also an excellent
`processing aid, decreasing barrel presstire, drive
`amps, and torque as the TPGS percent increased.
`TPGS rnay also act to prevent. polymer degrada.
`tioo wben utilized in the extrusion process. In
`summary, the unique properties of Vitamin E
`TPGS can function to promote more applicaliom
`and opportunities in wound care and in transder(cid:173)
`mal)transmucosal drug delivery.
`
`Ackno~·ledgt'ments
`
`Micbael A. Repka would like lO tbaok rbe
`American Fouudation for Pharmaceutical Educa(cid:173)
`tion for irs suppon ol' this study and other re(cid:173)
`search endeavors.
`
`Rererenccs
`
`Argao. E.A .. Heubi, J.E., Holl1s. B.W .. Tsang. R.C .. 1992.
`D-Aipba-tocopheryl polyethylene: glycol-1000 succinate en(cid:173)
`hances the absorption of vitamin D in chrome cholestauc
`
`BNSDOCID <XP
`
`, 1S3717A
`
`I >
`
`MSL_0003146
`
`RBP_TEVA05018004
`
`TEVA EXHIBIT 1042
`TEVA PHARMACEUTICALS USA, INC. V. MONOSOL RX, LLC
`
`

`
`70
`
`Af.A. Repka, .I.W. ft.1c(iinily lnt~mauonal Journal of Pharmar·eulic.< 202 (2001)) 6.1--70
`
`XP00118371l
`
`SokoL R.J., Juhnson. K.E .. Karr~r. F.M., Narkewicz, M.R..
`Kam, 1., eta!., 199la. lmprovcmcnt of cyclosporin absorp(cid:173)
`uon m chtldrcn aflcr hvcr transplantation by means of
`water-soluble vitamin E. Lancet 3;\8. 212··215.
`Sokol, R.J., Johnson, K.E .. Karrer, F.M., Narkcwicz, M.R ..
`Kam, I., el aL 1991 b. Improvement of cyclosporin absorp(cid:173)
`tion in childtcn after hvcr transplantation by means of
`water-soluble vitamin E. Lancet 3J8. 697.
`Sokol, R.J .. Butler-Simon. N .. Conner. C., Heubi . .J.F.., Sina(cid:173)
`tra. F.R., Suchy, F . .l., Heyman. M.B .. PerTault, J., Roth(cid:173)
`baWl>, R.J., l.evy. J .. et a!.. 199:1. Multicenter tnal of
`D-alph<Ho.:opb.:ryl polyethylene glycol 1000 .succinate for
`trr.atmenl of vitamin E deficiency in children witb chronic
`cholc:stasis. Gaslroeotrrology 104, 177.7-17.l5.
`Ttabca, M.G., Kayd<n. H.J .. Green, .l.B .. GJ<:eu. M.H., 198(j.
`Absorption or wattr·rrusctble forms of vitarrnu E
`tn a
`patient with ,:holesrasi~ and in thotnCtc dtJct-r.annulattd
`r·ats. Am. J. Clio. Nutr. 44, 914-923.
`Traher, M.G .. Tnellman, CA., Rindler, M J. Kayden. H.J.,
`
`inracr TPGS
`(D-alpha-rowpheryl
`1987. Upral<c of
`polyethylene glycol 1000 succtnat<•) a water--misctbk form
`of vitamin E by lwman cells iD vitro. Gastrc>enterology 93.
`975 9l>5.
`Trab~r. M.G .. Schiano, T.D., St~cphcn. A.C.. Kay;kn. H.J.,
`Shike. M .. 1994. Efficacy of water-soluhlc vitamtn E tn the
`trc~tmcnt of vitamin E malabsorption in short·bowcl ;y11·
`dromc. Am . .1. C:lin. Nutr. 59, 1270-1274.
`Wang. C.. Zhaug, G., Shab, N.H., lnfcld. M.H., Malick,
`A.W .• McGinity. J.W., 1996. Mechanical properties of
`stngle pellets containmg acrylic polymers. Pharrn. Dc:v.
`Techno!. J, 711-222.
`Whcaclcy. T.A .. Stcucraagcl. C.R., !997. Latex emulsions for
`controlle<J dntg dclivay.
`Jn: McGiwty. J. W.
`(Ed ).
`Aqueous Polymeric Coatings For Pharmaceutical Dosagt·
`Forms. Second eel. Marcel Oekker. New y.._,rk. pp U-
`52.
`Zhang. F .. McGintty, .J.W .. 1999. Properties of sustain,d-rc(cid:173)
`leasc tablets prepared by hot-wclc extrusion. Pharro. lkv.
`T~chnol. 4. 241-250.
`
`8NSOOCID. •XP.
`
`·' l837l7A ____ I_>
`
`MSL_0003147
`
`RBP_TEVA05018005
`
`TEVA EXHIBIT 1042
`TEVA PHARMACEUTICALS USA, INC. V. MONOSOL RX, LLC

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket